29 research outputs found
Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study
Get PDFIncidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease‐modifying antirheumatic drugs
No full textThe interaction of a single-nucleotide polymorphism with age on response to interferon-α and ribavirin therapy in female patients with hepatitis C infection
No full textEvaluation of the highly sensitive chemiluminescent enzyme immunoassay “Lumipulse HBsAg-HQ” for hepatitis B virus screening
No full textSurvival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan
No full textEstimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b
No full textDoes elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?
No full textRestoration of natural killer cell activity by pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C patient
No full text
Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C
No full text
